ThymulinWhat the studies show

Q: What kind of evidence exists for thymulin?

Animal and lab studies. A well-characterised hormone whose human data cover only its natural levels in zinc deficiency; the pain findings are rat and mouse studies from one group, and no trial has given thymulin to people.

A nine-amino-acid thymus hormone that only works with a zinc atom attached, found in 1977 and studied for pain and inflammation in rodents.

5 min read · Animal and lab studies · Updated November 2026

In short

Name: thymulin
Evidence: Animal and lab studies
Bottom line: A well-characterised hormone whose human data cover only its natural levels in zinc deficiency; the pain findings are rat and mouse studies from one group, and no trial has given thymulin to people.

Before you read this

This guide explains what published studies found. That is all it is.

It is not medical advice and it is not instructions for using anything. Where a dose appears, we are reporting what a named study gave the people or animals in it — a fact about the study, not an instruction to you.

The compounds here are not approved by the FDA for use in people and are sold for laboratory research only. A study tells you what happened to the subjects in it; it does not tell you what would happen to you. Talk to a doctor first.

What it is

Thymulin is a nine-amino-acid peptide hormone made by the epithelial cells of the thymus, the organ behind the breastbone where T cells mature. It was described in 1977 by Jean-François Bach's laboratory in Paris, which isolated it from pig serum and at first called it "facteur thymique sérique", serum thymic factor ¹. Five years later the same group found something unusual: the peptide does nothing on its own and becomes active only when a zinc ion binds to it, so the hormone is really the peptide-zinc complex ². Its original job description was to help T cells mature and to keep immune responses in proportion. The thymus shrinks steadily from adolescence onward, and the amount of active thymulin in blood falls along with it, which is why the hormone keeps coming up in research on immune aging ³.

The rest of this guide is free

Unlock the Thymulin guide — and every other one

What the studies found, what they didn't, every source linked. Enter your email once; the link we send opens all of them on this device, plus one plain-language study breakdown a week.

Zinc

The zinc dependence turned out to matter in people. In a 1988 study, healthy men were kept on a diet low in zinc for months until they were mildly deficient; the activity of thymulin in their blood fell, even though the peptide itself was still there. Adding zinc to the blood samples in the lab switched the activity back on, and zinc supplements restored it in the men themselves ⁴. It is the one human study of thymulin that stands up, and it measured the body's own hormone rather than giving it as a drug. It also means that a low thymulin reading can be a zinc problem rather than a thymus problem.

Pain and inflammation in rodents

From the mid-1990s a group at the American University of Beirut, working with Bach's former colleagues in Paris, studied thymulin for pain. Endotoxin — a piece of bacterial wall — injected into a rat's paw makes the paw tender for hours; in a 1996 study, thymulin given beforehand reduced that tenderness in both rats and mice, and the authors linked it to lower levels of the inflammatory signals the endotoxin sets off ⁵.

The direction was not fixed, though. In a 2000 paper the same group injected thymulin on its own into the paw at higher doses and found that it caused tenderness itself, through the same cytokines and prostaglandin E2 that drive inflammation ⁶. Low doses against endotoxin eased pain; higher doses alone produced it. That pattern — helpful in one setting, the opposite in another — is why the group went on to design modified versions of the peptide, and it is a caution against reading the 1996 result on its own.

Old animals

A group in La Plata, Argentina, took a different route. Nude mice have no thymus and therefore no thymulin, and the group built a gene that makes a thymulin-like peptide and delivered it to the mice; serum thymulin rose, and some of the pituitary hormone deficits that thymus-less animals develop were corrected ³. They proposed the same approach for aged animals, where thymulin has fallen with the thymus, but that is rodents and gene therapy — two steps from anything in people.

In people

Beyond the zinc-deficiency work there is no published randomized trial of thymulin given to people, and it is not an approved medicine anywhere. The hormone is well characterised — its sequence, its zinc requirement, where it is made, how it declines with age — but the only evidence that giving it does something comes from rats and mice, nearly all from one group, with the dose-dependent reversal above still unexplained.

What these studies are, and aren't

Animal and lab studies. A well-characterised hormone whose human data cover only its natural levels in zinc deficiency; the pain findings are rat and mouse studies from one group, and no trial has given thymulin to people.